When looking for the best stocks to buy and watch, focus on those with rising relative price strength.
One stock that fits that bill is Gilead Sciences stock, which had its Relative Strength (RS) Rating upgraded from 78 to 81 Thursday.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
IBD's unique RS Rating measures technical performance by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the last 52 weeks matches up against the rest of the market.
Decades of market research reveals that the top-performing stocks typically have an RS Rating north of 80 in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Is Gilead Sciences Stock A Buy?
Gilead Sciences stock is working on a flat base with an 89.84 buy point. See if the stock can break out in heavy trading. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips.
The biotech firm posted negative growth for both sales and earnings last quarter.
Gilead Sciences stock holds the No. 71 rank among its peers in the Medical-Biomed/Biotech industry group. Arcturus Therapeutics and Vertex Pharmaceuticals are also among the group's highest-rated stocks. For more industry news, check out "Biotech And Pharmaceutical Industry And Stock News."
